CRISPR/Cas9-mediated GLA gene editing in human iPSC-derived ventricular cardiomyocytes as a model of Fabry cardiomyopathy

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies: genetics, biomarkers and diagnostics Gene Therapy, Cell Therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology